Ironwood Pharmaceuticals, Inc.
IRWD
$1.55
-$0.06-3.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.89M | -32.34M | 880.00K | -2.46M | 9.21M |
| Total Depreciation and Amortization | 2.34M | 2.38M | 2.41M | 2.44M | 2.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.38M | 91.63M | 100.28M | 99.15M | 104.56M |
| Change in Net Operating Assets | -52.85M | 16.85M | -24.00K | 25.04M | 30.93M |
| Cash from Operations | 29.99M | 78.52M | 103.55M | 124.17M | 146.74M |
| Capital Expenditure | -49.00K | -105.00K | -142.00K | -353.00K | -386.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -3.98M | -26.55M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -49.00K | -105.00K | -142.00K | -4.33M | -26.94M |
| Total Debt Issued | 0.00 | 150.00M | 150.00M | 150.00M | 150.00M |
| Total Debt Repaid | -40.00M | -240.00M | -265.00M | -275.00M | -325.00M |
| Issuance of Common Stock | 297.00K | 958.00K | 11.01M | 11.81M | 11.82M |
| Repurchase of Common Stock | 0.00 | -121.00K | -737.00K | -737.00K | -737.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.25M | -2.25M | -2.25M | -29.06M | -26.90M |
| Cash from Financing | -41.95M | -91.41M | -106.97M | -142.99M | -190.82M |
| Foreign Exchange rate Adjustments | -659.00K | -63.00K | -32.00K | -103.00K | -80.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.67M | -13.06M | -3.60M | -23.25M | -71.10M |